Literature DB >> 22261555

Conjunction of tumor cells with lymphocytes: implications for tumor invasion and metastasis.

Guohong Song1, Jun Ren, Alexander Stojadinovic, Wen Chen, Ziad Sahab, Sidney W Fu, Yan-gao Man.   

Abstract

Our previous studies have led to a novel hypothesis that tumor metastasis is triggered by aberrant lymphocyte infiltration that disrupts intercellular junctions and surface adhesion molecules and causes dissociation of tumor cells from the primary tumor core, allowing lymphocytes to conjoin with dissociated tumor cells and physically 'drag' them to different tissue sites. Our hypothesis is supported by morphological and immunohistochemical data from multiple types of human cancer. This hypothesis challenges the traditional belief that the physical conjunction between tumor cells and lymphocytes would lead to degeneration of the tumor cells. To validate our hypothesis, H&E and immunostained sections were examined under high magnification to identify potential signs of degeneration-related changes. Our study revealed that >60% of isolated tumor cells overlying focal capsule disruptions, or within the stroma and vascular structures, were physically conjoined with lymphocytes to form tumor cell-lymphocyte chimeras (TLCs). Approximately 90% of the tumor cell partners of TLCs were morphologically indistinguishable from their counterparts within the tumor core. In addition, one third of the tumor cells of TLCs expressed high levels of cell proliferation specific proteins, or were undergoing mitosis. Our study also revealed that a subset of dilated lymphatic ducts or blood vessels at the site of focal capsule disruptions harbored variable numbers of tumor cells, and the wall of these structures was in direct physical continuity with the myoepithelial cell layer. Our study suggests that the onset of tumor metastasis may occur in two forms: (1) lymphocyte-mediated shuttling that allows lymphocytes to physically 'drag' tumor cells to different sites, and (2) tumor progenitor-mediated angiogenesis that allows tumor cells to directly enter the vascular structures.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22261555     DOI: 10.1016/j.canep.2011.12.006

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  4 in total

1.  Low-risk population among patients with tumor-node-metastasis stage III/IV oral squamous cell carcinoma.

Authors:  Tohru Ikeda; Sachiko Seki; Mutsunori Fujiwara; Masaaki Matsuura; Yuu Ozaki-Honda; Shuichi Fujita; Hisazumi Ikeda; Masahiro Umeda; Izumi Asahina
Journal:  Oncol Lett       Date:  2017-07-15       Impact factor: 2.967

2.  Pharmacodynamic study of 131I-labeled CA215 antibody on an animal model of estrogen-resistant OC-3-VGH ovarian cancer.

Authors:  Xiang-Yun Liu; Xin Su; Chen-Jing Xie; Lei Li; Jian-Yan Yan; Zu-Yue Sun
Journal:  Exp Ther Med       Date:  2015-05-26       Impact factor: 2.447

3.  Tumor-infiltrating immune cells: triggers for tumor capsule disruption and tumor progression?

Authors:  Bin Jiang; Jeffrey Mason; Anahid Jewett; Min-ling Liu; Wen Chen; Jun Qian; Yijiang Ding; Shuqing Ding; Min Ni; Xichen Zhang; Yan-gao Man
Journal:  Int J Med Sci       Date:  2013-03-05       Impact factor: 3.738

4.  Tube-like structures with co-expression of D2-40 and CD34: newly formed vasculatures?

Authors:  Bin Jiang; Jeffrey Mason; Anahid Jewett; William C S Cho; Yan-gao Man
Journal:  Int J Biol Sci       Date:  2012-10-19       Impact factor: 6.580

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.